Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody-mediated Rejection in Kidney Transplant”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Testing effectiveness (Phase 2)Ended earlyNCT01095887
What this trial is testing

Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation

Who this might be right for
Kidney Transplant
Mayo Clinic 6
Testing effectiveness (Phase 2)Study completedNCT02936479
What this trial is testing

C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection

Who this might be right for
Antibody Mediated Rejection of Kidney Transplant
NYU Langone Health 1
Large-scale testing (Phase 3)Study completedNCT04302805
What this trial is testing

RATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)

Who this might be right for
Kidney Transplantation
Institute for Clinical and Experimental Medicine 17
Testing effectiveness (Phase 2)WithdrawnNCT01035593
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation

Who this might be right for
Graft RejectionKidney Transplantation
Pharming Technologies B.V.
Large-scale testing (Phase 3)Looking for participantsNCT06685757
What this trial is testing

Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)

Who this might be right for
Antibody-mediated Rejection
Biogen 120
Testing effectiveness (Phase 2)Study completedNCT00670774
What this trial is testing

Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant

Who this might be right for
Kidney Transplant
Mark Stegall 31
Testing effectiveness (Phase 2)WithdrawnNCT02113891
What this trial is testing

Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation

Who this might be right for
Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Study completedNCT02201576
What this trial is testing

Bortezomib in Rejection of Kidney Transplants

Who this might be right for
Chronic Antibody-mediated Transplant Rejection
Assistance Publique - Hôpitaux de Paris 60
Not applicableStudy completedNCT02294032
What this trial is testing

The Role of B Cells in Kidney Allograft Dysfunction

Who this might be right for
Kidney; Complications, AllograftTransplantation Infection
Loma Linda University 180
Not applicableLooking for participantsNCT07006532
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab

Who this might be right for
Kidney Transplant Rejection
Shahid Beheshti University of Medical Sciences 50
Testing effectiveness (Phase 2)Looking for participantsNCT06503731
What this trial is testing

Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)

Who this might be right for
Antibody-mediated Rejection
argenx 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Not applicableStudy completedNCT05452317
What this trial is testing

Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection

Who this might be right for
Antibody-mediated Rejection in Kidney Transplant
CSL Behring 52
Large-scale testing (Phase 3)Ended earlyNCT02547220
What this trial is testing

Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

Who this might be right for
Acute Antibody-Mediated Rejection (AMR)
Shire 39
Not applicableUnknownNCT05913596
What this trial is testing

The Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal Transplantation

Who this might be right for
Antibody-mediated RejectionKidney Tranplant
First Affiliated Hospital of Zhejiang University 15
Not applicableStudy completedNCT04026087
What this trial is testing

Subclass of Donor-specific Antibody as a Risk Factor of Antibody Mediated Rejection in Renal Transplantation

Who this might be right for
Antibody-mediated Rejection
University Hospital, Montpellier 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06291103
What this trial is testing

Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)

Who this might be right for
Kidney Transplant Rejection
University Hospital, Rouen 290
Not applicableStudy completedNCT04541914
What this trial is testing

Diagnostic Efficacy of Molecular Diagnostic Method for AMR in ABOiKT

Who this might be right for
ABO Blood Type Incompatible Kidney TransplantationAntibody-mediated Rejection
Seoul National University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01147302
What this trial is testing

A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection

Who this might be right for
Graft Rejection
Shire 18
Not applicableStudy completedNCT04851145
What this trial is testing

Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation.

Who this might be right for
Kidney TransplantationGraft RejectionHumoral Immunity+1 more
University Hospital, Bordeaux 141
Load More Results